PMV Pharma shareholders elect directors, approve say-on-pay, ratify auditor at 2024 annual meeting

PMV Pharmaceuticals, Inc.

Class I directors Kirsten Flowers and Carol Gallagher elected with 35.7M and 27.1M votes for, respectively.
Non-binding advisory vote on executive compensation approved: 34.5M for, 1.1M against, 0.8M abstain.
Ratification of Ernst & Young as independent auditor for FY2024 passed with 43.5M for, 90.9K against.
Broker non-votes: 7.2M on director elections and say-on-pay proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.